Evotaz®: Clinical Trials

2 trials of Evotaz®, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1
Phase 31Completed 1

Follow Evotaz®: new trials by email Literature Review of Evotaz® trials Research Report on Evotaz®

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetic Effect of Evotaz/Microgynon Co-administration
Microgynon 30®, Evotaz® - HIV
Phase 1TerminatedSt Stephens Aids Trust132016-07-012018-01-02
Study to Evaluate the Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darunavir Plus Either Emtricitabine/Tenofovir or Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Infected Adults
RTV, ATV, DRV - HIV-1 Infection
Phase 3CompletedGilead Sciences5782015-11-202020-12-29

Sponsors

Gilead Sciences (1)  ·  St Stephens Aids Trust (1)

Countries

United Kingdom (2)  ·  Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  Dominican Republic (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Puerto Rico (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Marta Boffito (1)

Results publications

PMID 29925490, PMID 31430369, PMID 36912172

NIH funding

2015 (1)